Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chidamide with CHOPE for Peripheral T-Cell Lymphoma
NCT03617432Phase 2Unknown
- Sponsor
- Peking University
- Start
- Aug 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in peripheral T-cell lymphoma (PTCL), sponsored by Peking University. Status: unknown.
02
Drugs
tucidinostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03617432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03617432.